These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 8909306

  • 1. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS.
    Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306
    [Abstract] [Full Text] [Related]

  • 2. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC, Dublin EA, Camplejohn RS, Levison DA.
    Anal Cell Pathol; 1995 Jul 01; 9(1):45-52. PubMed ID: 7577754
    [Abstract] [Full Text] [Related]

  • 3. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS, Pirdas-Zivcic A.
    Pathology; 1994 Oct 01; 26(4):448-52. PubMed ID: 7892048
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours.
    Lee CS.
    Eur J Surg Oncol; 1998 Feb 01; 24(1):38-42. PubMed ID: 9542514
    [Abstract] [Full Text] [Related]

  • 6. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
    Lee CS.
    Eur J Surg Oncol; 1997 Jun 01; 23(3):233-7. PubMed ID: 9236898
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K, Nakano T, Hoshi T.
    Cancer; 1996 Jun 01; 77(11):2280-5. PubMed ID: 8635096
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M, Domagała W.
    Pol J Pathol; 1996 Jun 01; 47(4):189-94. PubMed ID: 9097711
    [Abstract] [Full Text] [Related]

  • 11. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO, Gelen T, Aksoy NH, Karpuzoglu T, Keles N.
    Pathol Oncol Res; 2000 Jun 01; 6(1):59-64. PubMed ID: 10749590
    [Abstract] [Full Text] [Related]

  • 12. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D, Palestro G.
    J Clin Pathol; 1994 Jan 01; 47(1):18-22. PubMed ID: 7907607
    [Abstract] [Full Text] [Related]

  • 13. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Jan 01; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 14. Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland.
    Zhu Q, Tipoe GL, White FH.
    Anal Quant Cytol Histol; 1999 Aug 01; 21(4):336-42. PubMed ID: 10560511
    [Abstract] [Full Text] [Related]

  • 15. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
    Yang WI, Efird JT, Quintanilla-Martinez L, Choi N, Harris NL.
    Hum Pathol; 1996 Jan 01; 27(1):70-6. PubMed ID: 8543314
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY, Law SY, So MK, Fok M, Ma LT, Wong J.
    Cancer; 1996 Jan 01; 77(1):7-13. PubMed ID: 8630942
    [Abstract] [Full Text] [Related]

  • 17. Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?
    Haitel A, Wiener HG, Migschitz B, Marberger M, Susani M.
    Am J Clin Pathol; 1997 Feb 01; 107(2):229-35. PubMed ID: 9024073
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
    Shyr YM, Su CH, Wu LH, Li AF, Chiu JH, Wu CW, Lui WY.
    Ann Surg; 1999 Apr 01; 229(4):523-7. PubMed ID: 10203085
    [Abstract] [Full Text] [Related]

  • 19. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan 01; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.
    Kubota K, Kakuta Y, Kawamura S, Saito S, Seki H, Kuniyoshi T.
    Pathol Int; 2003 Jun 01; 53(6):361-70. PubMed ID: 12787310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.